115 related articles for article (PubMed ID: 20925278)
1. [The prevalence of metabolic syndrome in women with polycystic ovary syndrome].
Vrbíková J; Hill M; Dvoráková K; Stanická S; Stárka L
Cas Lek Cesk; 2010; 149(7):337-9. PubMed ID: 20925278
[TBL] [Abstract][Full Text] [Related]
2. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B
Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650
[TBL] [Abstract][Full Text] [Related]
3. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.
Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J
Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.
Ehrmann DA; Liljenquist DR; Kasza K; Azziz R; Legro RS; Ghazzi MN;
J Clin Endocrinol Metab; 2006 Jan; 91(1):48-53. PubMed ID: 16249284
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome in young Czech women with polycystic ovary syndrome.
Vrbíková J; Vondra K; Cibula D; Dvoráková K; Stanická S; Srámková D; Sindelka G; Hill M; Bendlová B; Skrha J
Hum Reprod; 2005 Dec; 20(12):3328-32. PubMed ID: 16085666
[TBL] [Abstract][Full Text] [Related]
7. The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic-hyperinsulinaemic clamp study.
Tagliaferri V; Romualdi D; Guido M; Mancini A; De Cicco S; Di Florio C; Immediata V; Di Segni C; Lanzone A
Eur J Endocrinol; 2016 Nov; 175(5):433-41. PubMed ID: 27511825
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome.
Lankarani M; Valizadeh N; Heshmat R; Peimani M; Sohrabvand F
Gynecol Endocrinol; 2009 Aug; 25(8):504-7. PubMed ID: 19499403
[TBL] [Abstract][Full Text] [Related]
9. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.
Moghetti P; Tosi F; Bonin C; Di Sarra D; Fiers T; Kaufman JM; Giagulli VA; Signori C; Zambotti F; Dall'Alda M; Spiazzi G; Zanolin ME; Bonora E
J Clin Endocrinol Metab; 2013 Apr; 98(4):E628-37. PubMed ID: 23476073
[TBL] [Abstract][Full Text] [Related]
10. Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors.
Carmina E; Campagna AM; Lobo RA
Hum Reprod; 2013 Aug; 28(8):2245-52. PubMed ID: 23595974
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome in adolescents with polycystic ovary syndrome.
Vrbíková J; Zamrazilová H; Sedláčková B; Šnajderová M
Gynecol Endocrinol; 2011 Oct; 27(10):820-2. PubMed ID: 20807165
[TBL] [Abstract][Full Text] [Related]
12. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
Ságodi L; Lombay B; Vámosi I; Barkai L
Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
[TBL] [Abstract][Full Text] [Related]
13. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
[TBL] [Abstract][Full Text] [Related]
15. Could "a body shape index" and "waist to height ratio" predict insulin resistance and metabolic syndrome in polycystic ovary syndrome?
Behboudi-Gandevani S; Ramezani Tehrani F; Cheraghi L; Azizi F
Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():110-4. PubMed ID: 27579518
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features of the metabolic syndrome in patients with polycystic ovary syndrome].
Hu WH; Qiao J; Wang LN; Tong J
Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 42(2):159-63. PubMed ID: 20396356
[TBL] [Abstract][Full Text] [Related]
17. Association between the polycystic ovary syndrome and the metabolic syndrome in Puerto Rico.
Rabelo Acevedo M; Vick MR
P R Health Sci J; 2005 Sep; 24(3):203-6. PubMed ID: 16329683
[TBL] [Abstract][Full Text] [Related]
18. Lipid accumulation product is related to metabolic syndrome in women with polycystic ovary syndrome.
Xiang S; Hua F; Chen L; Tang Y; Jiang X; Liu Z
Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):115-8. PubMed ID: 23426706
[TBL] [Abstract][Full Text] [Related]
19. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
Cussons AJ; Watts GF; Burke V; Shaw JE; Zimmet PZ; Stuckey BG
Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531
[TBL] [Abstract][Full Text] [Related]
20. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
